People in the News: Tina Nova | GenomeWeb

People in the News: Tina Nova

Premium

NanoString Technologies has tapped Tina Nova to serve on its board of directors and to take a seat on its executive compensation committee.

Nova co-founded Genoptix and served as its president from 2000 to 2014, and she co-founded and was COO of Nanogen. Nova also was COO of Selective Genetics and she held various research and management positions at Ligand Pharmaceuticals and Hybritech.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.